From Dr. Laura Lubbers <[email protected]>
Subject Epilepsy Research News: January 2023
Date January 17, 2023 6:00 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
The latest epilepsy research on gene therapy, genetic testing, a WHO brief created to improve the lives of those with epilepsy, and more. 

View this email in your browser ([link removed])


** CURE Epilepsy is dedicated to funding patient-focused research to find a cure for the 65 million people with epilepsy worldwide. This month, we share the following articles and abstracts which are furthering the study of epilepsy and bringing the world closer to a cure.
------------------------------------------------------------
This issue of Epilepsy Research News includes summaries of articles on:
* Genetic Testing for Epilepsy Improves Patient Outcomes ([link removed])
* New Tools to Map Seizures and Improve Epilepsy Treatment ([link removed])
* Gene Therapy for Epilepsy ([link removed])
* World Health Organization (WHO) Focuses on Improving the Lives of People with Epilepsy ([link removed])
* Memory Impairment in Those with Epilepsy ([link removed])

Genetic Testing for Epilepsy Improves Patient Outcomes ([link removed])

Genetic testing in patients with epilepsy can inform treatment and lead to better outcomes in many cases, according to a new study. The study, led and funded by the genetic testing company Invitae, included patients referred for genetic testing between 2016 and 2020 whose testing revealed a positive molecular diagnosis. The investigators asked the patient’s healthcare providers how the results of the genetic test impacted the patient’s treatment plan and outcomes. Of the 418 children and adults with epilepsy who were included in the study, nearly half saw changes in their treatment plans such as a change in medication or referral to a specialist, after genetic testing revealed new information about their condition. The study also found that of 167 patients with follow-up information available, treatment changes were associated with improved patient outcomes including a reduction or elimination of seizures. The authors concluded that results support the use of genetic testing to guide the
clinical management of epilepsy to improve patient outcomes. Learn more about genetic testing for epilepsy here ([link removed]) .

Learn More ([link removed])
New Tools to Map Seizures and Improve Epilepsy Treatment ([link removed])
A new “tool” – a statistical model – has been developed to help doctors find precisely where seizures originate in the brain to increase the possibility of treating that specific region. Localizing where seizures begin is usually a costly and time-consuming process that can often require days to weeks of invasive monitoring. In this study, researchers aimed to shorten the time it takes to locate the seizure onset zone by studying patients' brains, both when they weren't having seizures and when their brains were stimulated with quick electrical pulses, to quickly create maps predicting where seizures begin. In the 65 patients studied, the model predicted the location of the onset of seizures and the ultimate success of surgical intervention with 79% accuracy. The researchers noted that this tool might be used to help clinicians identify the area where seizures begin in a less time-consuming process.

Learn More ([link removed])
Gene Therapy for Epilepsy ([link removed])
A recently published study shows that a potential new treatment can prevent seizures in mice by clearing the accumulation of a protein in the brain known as the tau protein. Researchers at Macquarie University recently found that accumulation of tau protein can lead to neurons becoming hyperexcited. Hyperexcited neurons that fire continuously can result in seizures and cognitive decline. In the newly published study, the researchers developed a gene therapy that uses a brain enzyme known as p38y to prevent this accumulation. When treated with the new gene therapy, mice with uncontrolled epilepsy had a better chance of survival in addition to reduced seizure susceptibility. The researchers note that their next step is to conduct a more detailed study in the laboratory, in hopes of eventually preparing the treatment for a possible clinical trial.
Learn More ([link removed])
World Health Organization (WHO) Focuses on Improving the Lives of People with Epilepsy ([link removed])
A technical brief published by the World Health Organization (WHO) called Improving the Lives of People with Epilepsy sets out the actions required to deliver an integrated approach to epilepsy care and treatment with the goal of meeting the multifaceted needs of people with epilepsy. In summary, the brief highlights the importance of:
* Integrated services across the life-course, particularly at the primary care level
* Access to anti-seizure medicines
* Resources and training for the health and social services workforce
* Anti-stigma and discriminatory legislation and practices; promoting and respecting the human rights and full social inclusion of people with epilepsy, their families and caregivers.

Learn More ([link removed])
Memory Impairment in Those with Epilepsy ([link removed])
People with chronic epilepsy often experience impaired memory. Researchers have now found a mechanism using a mouse model of epilepsy that could explain this impairment. Porous channels called ion channels within the brain allow electrically charged particles (ions) to flow into neurons, allowing neurons to communicate with each other. However, the researchers found changes in sodium ion channels within neurons of the hippocampus – an area of the brain important in learning and memory – that could lead to changes in the activity of these neurons and affect their normal function. When the researchers administered substances to restore the normal function of these channels, the firing properties of the neurons normalized, and the animals were better able to remember places they had visited. The study provides insight into the processes involved in memory retrieval. In addition, it provides support for the idea that the development of new drugs may improve the memory of epilepsy patients.
Learn More ([link removed])

============================================================
** ([link removed])
Today's research has the ability to help
the 65 million people worldwide who are
impacted by epilepsy every day.
And each one of those individuals has a story.
** Read Leonardo's story ([link removed])
** Facebook ([link removed])
** LinkedIn ([link removed])
** Twitter ([link removed])
** Instagram ([link removed])
** YouTube ([link removed])
** ([link removed])
Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research. CURE Epilepsy is a non-profit 501(c)(3) tax-exempt organization.Our tax identification number is 36-4253176.
Copyright © 2022 CURE Epilepsy, All rights reserved.
In the past you provided CURE Epilepsy your email address. Occasionally, you will receive updates from us about epilepsy research and news.

Our mailing address is:
CURE Epilepsy
420 Wabash Ave, Ste 650
Chicago, IL 60611
** Add us to your address book ([link removed])

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed][UNIQID]&c=c48d2dc567&utm_source=1+-+General+List&utm_campaign=219850b876-EMAIL_CAMPAIGN_Epilepsy+Research+News-jan+23&utm_medium=email&utm_term=0_daad723502-219850b876-281217465)
.

This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
CURE Epilepsy . 420 Wabash Ave, Ste 650 . Chicago, IL 60611 . USA
Screenshot of the email generated on import

Message Analysis